Christina Jane Vellan
YOU?
Author Swipe
View article: Proteomic Profiling of Serum of Women with Bi-Rads 1 to 5: Identification of Potential Complementary Biomarkers for Early Detection of Breast Cancer
Proteomic Profiling of Serum of Women with Bi-Rads 1 to 5: Identification of Potential Complementary Biomarkers for Early Detection of Breast Cancer Open
Mammography remains the gold standard for the screening of breast cancer (BrCa) despite its shortcomings. Cancer antigen 15-3, an FDA-approved biomarker, is most useful as a treatment response and recurrence monitoring tool rather than for…
View article: Application of Proteomics in Pancreatic Ductal Adenocarcinoma Biomarker Investigations: A Review
Application of Proteomics in Pancreatic Ductal Adenocarcinoma Biomarker Investigations: A Review Open
Pancreatic ductal adenocarcinoma (PDAC), a highly aggressive malignancy with a poor prognosis is usually detected at the advanced stage of the disease. The only US Food and Drug Administration-approved biomarker that is available for PDAC,…